Optimizing biomarker testing workflows and pharmacist involvement can improve precision oncology decision-making in non–small cell lung cancer.
Lisa Lasita, PharmD, MBA
Advertisement
Articles by Lisa Lasita, PharmD, MBA
Successfully integrating biosimilars into practices requires careful planning and execution, as they impact virtually all aspects of a practice.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Metformin Cuts Long COVID Risk by 50%, New Trial Confirms
2
Phase 3 MonumenTAL-3 Trial Demonstrates Significant Survival Benefit With Talquetamab-Based Regimens in Relapsed/Refractory Multiple Myeloma
3
Halfway There Is Nowhere
4
Combined Food Policies, Including Labeling and Advertising Bans, Plausibly Reduce Childhood Obesity
5